New approaches to antipsychotic medication adherence – safety, tolerability and acceptability
Authors:
- 29 September 2021
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 21 (4) , 517-524
Abstract
Antipsychotic pharmacotherapy is considered first-line treatment in schizophrenia-related disorders and is associated with favorable prognosis and lower mortality rates. However, low adherence rate...Keywords
This publication has 70 references indexed in Scilit:
- Practitioner attitudes to clozapine initiationActa Psychiatrica Scandinavica, 2013
- Psychopharmacology of Aggression in SchizophreniaSchizophrenia Bulletin, 2011
- Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with SchizophreniaClinical Pharmacokinetics, 2009
- Transdermal drug deliveryNature Biotechnology, 2008
- Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophreniaBMC Psychiatry, 2008
- Why aren't depot antipsychotics prescribed more often and what can be done about it?Advances in Psychiatric Treatment, 2005
- Risk Facotrs for Posttraumatic Stress DisorderThe Journal of Clinical Psychiatry, 2000
- Randomised controlled trial of compliance therapyThe British Journal of Psychiatry, 1998
- Adverse Effects of Antipsychotic AgentsDrugs, 1996
- Long Term Depot AntipsychoticsDrug Safety, 1994